The pharmacy, Infusion Resource, was also found to have a center for giving intravenous medications to patients in violation of state regulations, which require a clinic license, Dr. Madeleine Biondolillo, director of the Massachusetts Department of Public Health Bureau of Healthcare Safety and Quality, said Sunday.
"It is correct that Infusion Resource does not have a clinic license from the Commonwealth of Massachusetts.
That announcement came in the wake of the fungal meningitis outbreak that has caused 25 deaths and 354 illnesses, linked to the Massachusetts-based New England Compounding Center.
Infusion Resource is not linked to the outbreak.
The Department of Public Health has asked two other companies -- Ameridose and Alaunus Pharmaceutical -- to cease all pharmacy operations based on their shared ownership and leadership with NECC.